EA200900260A1 - Гранулы и орально дезинтегрируемые таблетки, содержащие оксикодон - Google Patents
Гранулы и орально дезинтегрируемые таблетки, содержащие оксикодонInfo
- Publication number
- EA200900260A1 EA200900260A1 EA200900260A EA200900260A EA200900260A1 EA 200900260 A1 EA200900260 A1 EA 200900260A1 EA 200900260 A EA200900260 A EA 200900260A EA 200900260 A EA200900260 A EA 200900260A EA 200900260 A1 EA200900260 A1 EA 200900260A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- granules
- oxycodon
- tablets containing
- orally disintegrated
- disintegrated tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Настоящее изобретение относится к гранулам, включающим оксикодон, а также к орально дезинтегрируемым таблеткам, включающим его же и при необходимости ацетаминофен.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82144906P | 2006-08-04 | 2006-08-04 | |
PCT/EP2007/057912 WO2008015220A1 (en) | 2006-08-04 | 2007-07-31 | Granule and orally disintegrating tablet comprising oxycodone |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200900260A1 true EA200900260A1 (ru) | 2009-06-30 |
EA017832B1 EA017832B1 (ru) | 2013-03-29 |
Family
ID=38752477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200900260A EA017832B1 (ru) | 2006-08-04 | 2007-07-31 | Гранулы и орально дезинтегрируемые таблетки, содержащие оксикодон |
Country Status (15)
Country | Link |
---|---|
US (1) | US8465776B2 (ru) |
EP (1) | EP2046285B1 (ru) |
JP (1) | JP5421775B2 (ru) |
KR (1) | KR101445757B1 (ru) |
CN (1) | CN101534792B (ru) |
AU (1) | AU2007280470B2 (ru) |
BR (1) | BRPI0714514B8 (ru) |
CA (1) | CA2659122C (ru) |
EA (1) | EA017832B1 (ru) |
ES (1) | ES2667944T3 (ru) |
IL (1) | IL196741A (ru) |
MX (1) | MX2009001294A (ru) |
NZ (1) | NZ574544A (ru) |
WO (1) | WO2008015220A1 (ru) |
ZA (1) | ZA200900640B (ru) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
EP1429739A1 (en) | 2001-09-21 | 2004-06-23 | Egalet A/S | Polymer release system |
WO2004084868A1 (en) | 2003-03-26 | 2004-10-07 | Egalet A/S | Morphine controlled release system |
JP5497435B2 (ja) * | 2006-08-04 | 2014-05-21 | エチファーム | 多層口腔内崩壊錠剤 |
WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
JP5648480B2 (ja) * | 2008-10-24 | 2015-01-07 | 東レ株式会社 | 4,5−エポキシモルヒナン誘導体を含有する安定な錠剤 |
US9005660B2 (en) | 2009-02-06 | 2015-04-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
RU2554740C2 (ru) * | 2009-05-01 | 2015-06-27 | Апталис Фарматек, Инк. | Композиции перорально распадающихся таблеток, содержащие комбинации высоко- и низкодозовых лекарственных средств |
CA2766179A1 (en) | 2009-06-24 | 2010-12-29 | Egalet Ltd. | Controlled release formulations |
US20110150989A1 (en) * | 2009-12-22 | 2011-06-23 | Mallinkckrodt Inc. | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US20130240384A1 (en) * | 2010-08-18 | 2013-09-19 | Purdue Pharma L.P. | Vacuum Avoiding Packaging Systems and Methods Thereof |
CN102178657B (zh) * | 2011-04-11 | 2017-05-31 | 浙江华海药业股份有限公司 | 一种奥氮平口腔崩解片 |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
KR102154880B1 (ko) | 2012-05-03 | 2020-09-10 | 칼라 파마슈티컬스, 인크. | 개선된 점막 수송을 나타내는 제약 나노입자 |
US9827191B2 (en) | 2012-05-03 | 2017-11-28 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
US11596599B2 (en) | 2012-05-03 | 2023-03-07 | The Johns Hopkins University | Compositions and methods for ophthalmic and/or other applications |
EP2844295A1 (en) | 2012-05-03 | 2015-03-11 | Kala Pharmaceuticals, Inc. | Pharmaceutical nanoparticles showing improved mucosal transport |
EP2877161A1 (en) | 2012-07-06 | 2015-06-03 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
PL2872121T3 (pl) | 2012-07-12 | 2019-02-28 | SpecGx LLC | Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania |
KR101340733B1 (ko) * | 2012-12-31 | 2013-12-12 | (주) 에프엔지리서치 | 신규한 마이크로그래뉼 제형 |
EP2801349A1 (en) | 2013-05-06 | 2014-11-12 | Siegfried AG | Oral Pharmaceutical Formulation |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015065547A1 (en) | 2013-10-31 | 2015-05-07 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
CA2955229C (en) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
EP3209282A4 (en) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
GR1008992B (el) | 2015-12-17 | 2017-03-23 | Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων | Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης |
JP6905972B2 (ja) * | 2016-02-23 | 2021-07-21 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
JP6915258B2 (ja) * | 2016-10-21 | 2021-08-04 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
KR102120720B1 (ko) * | 2018-07-16 | 2020-06-10 | 연성정밀화학(주) | 날푸라핀 함유 구강붕해정 |
CN109512796A (zh) * | 2018-12-26 | 2019-03-26 | 甘肃普安制药股份有限公司 | 一种氨酚羟考酮胶囊填充方法 |
WO2020225773A1 (en) | 2019-05-07 | 2020-11-12 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
CN113842376A (zh) * | 2020-06-28 | 2021-12-28 | 齐鲁制药有限公司 | 一种含有利培酮的药物组合物和口溶膜剂及制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
FR2679451B1 (fr) | 1991-07-22 | 1994-09-09 | Prographarm Laboratoires | Comprime multiparticulaire a delitement rapide. |
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
US5286493A (en) | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
CA2128820A1 (en) | 1993-07-27 | 1995-01-28 | Walter G. Gowan, Jr. | Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof |
EP2036558A3 (en) * | 1993-10-07 | 2010-04-28 | Euro-Celtique S.A. | Orally administrable opioid formulations having extended duration of effect |
US6024981A (en) | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
FR2766089B1 (fr) * | 1997-07-21 | 2000-06-02 | Prographarm Lab | Comprime multiparticulaire perfectionne a delitement rapide |
ATE219658T1 (de) | 1998-03-06 | 2002-07-15 | Eurand Int | Schnell zerfallende tablette |
MY154010A (en) * | 1998-07-28 | 2015-04-30 | Takeda Pharmaceutical | Rapidly disintegrable solid preparation |
FR2785538B1 (fr) | 1998-11-06 | 2004-04-09 | Prographarm Laboratoires | Comprime a delitement rapide perfectionne |
JP2002530322A (ja) * | 1998-11-25 | 2002-09-17 | シーマ・ラブス・インコーポレイテッド | 味隠蔽迅速放出コーティング系 |
US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
FR2790387B1 (fr) | 1999-03-01 | 2001-05-18 | Prographarm Laboratoires | Comprime orodispersible presentant une faible friabilite et son procede de preparation |
DK1416842T3 (da) * | 2001-07-18 | 2009-03-16 | Euro Celtique Sa | Farmaceutiske kombinationer af oxycodon og naloxon |
US20030044458A1 (en) * | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
CN1652752A (zh) * | 2002-03-14 | 2005-08-10 | 欧罗赛铁克股份有限公司 | 盐酸纳曲酮组合物 |
FR2850576B1 (fr) * | 2003-02-05 | 2007-03-23 | Ethypharm Sa | Composition comprenant un melange de principes actifs, et procede de preparation |
WO2006127879A1 (en) * | 2005-05-26 | 2006-11-30 | Duramed Pharmaceuticals, Inc. | Flexible solid dosage forms and methods of making and using the same |
US8900637B2 (en) * | 2005-12-02 | 2014-12-02 | Lupin Limited | Stable taste masked formulations of cephalosporins |
JP5497435B2 (ja) * | 2006-08-04 | 2014-05-21 | エチファーム | 多層口腔内崩壊錠剤 |
-
2007
- 2007-07-31 WO PCT/EP2007/057912 patent/WO2008015220A1/en active Application Filing
- 2007-07-31 NZ NZ574544A patent/NZ574544A/en unknown
- 2007-07-31 ES ES07788099.5T patent/ES2667944T3/es active Active
- 2007-07-31 EP EP07788099.5A patent/EP2046285B1/en active Active
- 2007-07-31 EA EA200900260A patent/EA017832B1/ru not_active IP Right Cessation
- 2007-07-31 AU AU2007280470A patent/AU2007280470B2/en active Active
- 2007-07-31 KR KR1020097002243A patent/KR101445757B1/ko active IP Right Grant
- 2007-07-31 MX MX2009001294A patent/MX2009001294A/es active IP Right Grant
- 2007-07-31 JP JP2009522247A patent/JP5421775B2/ja active Active
- 2007-07-31 CA CA2659122A patent/CA2659122C/en active Active
- 2007-07-31 US US12/376,060 patent/US8465776B2/en active Active
- 2007-07-31 BR BRPI0714514A patent/BRPI0714514B8/pt active IP Right Grant
- 2007-07-31 CN CN2007800363003A patent/CN101534792B/zh active Active
- 2007-07-31 ZA ZA200900640A patent/ZA200900640B/xx unknown
-
2009
- 2009-01-27 IL IL196741A patent/IL196741A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR101445757B1 (ko) | 2014-10-02 |
AU2007280470A1 (en) | 2008-02-07 |
CN101534792B (zh) | 2013-02-20 |
IL196741A0 (en) | 2009-11-18 |
MX2009001294A (es) | 2009-05-21 |
ES2667944T3 (es) | 2018-05-16 |
EA017832B1 (ru) | 2013-03-29 |
JP2009545560A (ja) | 2009-12-24 |
CA2659122C (en) | 2016-08-23 |
AU2007280470B2 (en) | 2013-03-14 |
CN101534792A (zh) | 2009-09-16 |
US8465776B2 (en) | 2013-06-18 |
CA2659122A1 (en) | 2008-02-07 |
ZA200900640B (en) | 2010-06-30 |
BRPI0714514A2 (pt) | 2013-07-02 |
IL196741A (en) | 2015-05-31 |
WO2008015220A8 (en) | 2008-04-03 |
EP2046285A1 (en) | 2009-04-15 |
KR20090034372A (ko) | 2009-04-07 |
WO2008015220A1 (en) | 2008-02-07 |
JP5421775B2 (ja) | 2014-02-19 |
NZ574544A (en) | 2011-12-22 |
BRPI0714514B1 (pt) | 2020-01-07 |
US20090304792A1 (en) | 2009-12-10 |
EP2046285B1 (en) | 2018-02-21 |
BRPI0714514B8 (pt) | 2021-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200900260A1 (ru) | Гранулы и орально дезинтегрируемые таблетки, содержащие оксикодон | |
BRPI0607975A2 (pt) | forma farmacêutica contendo oxicodona e naloxona | |
EA201300465A1 (ru) | Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик | |
EA200870357A1 (ru) | Производные тетрагидроизохинолина для повышения функции памяти | |
EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
EA200900023A1 (ru) | Применение замещенных 2-аминотетралинов для изготовления лекарственного средства для предупреждения, облегчения и/или лечения разных видов боли | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
CY1110209T1 (el) | Υποκατεστημενες ενωσεις βενζο(d)ισοξαζολ-3-υλ-αμινης σαν αναλγητικα | |
EA201690265A3 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
MX2008001799A (es) | Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv. | |
ATE488232T1 (de) | P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen | |
GB2437009A (en) | Ranking system | |
EA201170753A1 (ru) | Налмефена гидрохлорид дигидрат | |
ES1071119Y (es) | Conector de bloqueo eficaz. | |
EA200870515A1 (ru) | Моноциклические гетероарильные соединения | |
ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
CY1114023T1 (el) | Διυποκατεστημενης φθαλαζινης ανταγωνιστες σηματοδοτικης οδου hedgehog | |
CL2011001122A1 (es) | Compuestos derivados de carbamatos de alquilheterociclos; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir o tratar dolores agudos o cronicos, patologias neurologicas y psiquiatricas, enfermedades cardiovasculares, entre otras. | |
EA200900261A1 (ru) | Применение эсцина | |
DE502006000330D1 (de) | Steckergehäuse | |
EA201001353A1 (ru) | Гидробромид ивабрадина | |
FR2889518B1 (fr) | Systeme pour le traitement des eaux usees domestiques | |
ATE533477T1 (de) | Pharmazeutische zusammensetzungen enthaltend irbesartan | |
FR2905600B1 (fr) | Traitement des vertiges par l'acetyl-l-leucine. | |
HK1131156A1 (en) | Novel morphine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY RU |